DIGOXIGENIN

SynDRA canonical compound SYN0004139 — structure-anchored drug synonym record

Clinical phase	Preclinical
Mechanism of action	steroid

Mechanisms of action (all sources)

Lanadigenin
Digoxigenine
CHEBI:42098
NQ1SX9LNAU
Card-20(22)-enolide, 3,12,14-trihydroxy-, (3beta,5beta,12beta)-
3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3,12,14-trihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
4-((3S,5R,8R,9S,10S,12R,13S,14S,17R)-3,12,14-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one
3beta,12beta,14-Trihydroxy-5beta,20(22)-cardenolide
3beta,12beta,14-trihydroxy-5beta-card-20(22)-enolide
Card-20(22)-enolide, 3,12,14-trihydroxy-, (3ss,5ss,12ss)-
3beta,12beta,14beta,21-Tetrahydroxy-20(22)-norcholenic acid lactone
HSDB 7108
SR-01000841253
UNII-NQ1SX9LNAU
EINECS 216-806-2
BRN 0096479
Lanadigigenin
1lke
A-Digoxigenin
4-(3,12,14-TRIHYDROXY-10,13-DIMETHYL-HEXADECAHYDRO-CYCLOPENTA[A]PHENANTHREN-17-YL)-5H-FURAN-2-ONE
CAS-1672-46-4
3-beta,12-beta,14-Trihydroxy-card-20(22)-enolide
3-beta,12,14-Trioxy-digen-(20:22)-olid [German]
3-beta,12,14-Trioxy-carden-(20:22)-olid [German]
Cardogenen-(20:22)-triol-(3-beta,12,14) [German]
4j8t
4j9a
(3beta,5beta,12beta)-3,12,14-Trihydroxycard-20(22)-enolide
DIGOXIGENIN [MI]
Prestwick0_000883
Prestwick1_000883
Prestwick2_000883
Prestwick3_000883
DIGOXIGENIN [HSDB]
bmse000735
Epitope ID:180303
3-beta,12,14-Trioxy-carden-(20:22)-olid